<p>Patients were stratified by high (n=45) and low (n=57) PCNA<sup>+</sup> TAMs. The difference between groups was significant using the log rank test (p=0.006).</p
<p>Kaplan-Meier plots for probability of survival at 90 days between high and low 3-NT/Tyr. Signific...
<p>Tick marks in Kaplan-Meier Estimates of recurrence-free survival indicate patients whose data wer...
<p>Kaplan-Meier plots depicting breast cancer related survival in response to rs12358475 genotypes i...
<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA<sup>+</sup> TAMs surrogate sc...
<p>(A) The RFS and (B) MFS differed significantly according to the adherence status (<i>P</i> = 0.00...
<p>(A) The RFS and (B) MFS differed significantly according to the adherence status (<i>P</i> = 0.00...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>Kaplan-Meier survival curves of patients grouped in the 10 clusters show significant survival dif...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>A: among all breast cancer patients; B: among patients without lymph node metastasis; C: among pa...
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breas...
<p>The patients were stratified by <i>ERG</i> rearrangement and Ki-67 LI in combination and log-rank...
<p>Kaplan-Meier estimates of breast cancer-specific survival in TNM stages III (A) and I & II (B) an...
<p>Log-rank test: <i>P</i> < 0.05. Within this follow-up period, 38 of the 173 patients (22%) died f...
(A) Distant metastasis-free survival and (B) breast cancer-specific survival in low-risk (n = 180) a...
<p>Kaplan-Meier plots for probability of survival at 90 days between high and low 3-NT/Tyr. Signific...
<p>Tick marks in Kaplan-Meier Estimates of recurrence-free survival indicate patients whose data wer...
<p>Kaplan-Meier plots depicting breast cancer related survival in response to rs12358475 genotypes i...
<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA<sup>+</sup> TAMs surrogate sc...
<p>(A) The RFS and (B) MFS differed significantly according to the adherence status (<i>P</i> = 0.00...
<p>(A) The RFS and (B) MFS differed significantly according to the adherence status (<i>P</i> = 0.00...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>Kaplan-Meier survival curves of patients grouped in the 10 clusters show significant survival dif...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>A: among all breast cancer patients; B: among patients without lymph node metastasis; C: among pa...
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breas...
<p>The patients were stratified by <i>ERG</i> rearrangement and Ki-67 LI in combination and log-rank...
<p>Kaplan-Meier estimates of breast cancer-specific survival in TNM stages III (A) and I & II (B) an...
<p>Log-rank test: <i>P</i> < 0.05. Within this follow-up period, 38 of the 173 patients (22%) died f...
(A) Distant metastasis-free survival and (B) breast cancer-specific survival in low-risk (n = 180) a...
<p>Kaplan-Meier plots for probability of survival at 90 days between high and low 3-NT/Tyr. Signific...
<p>Tick marks in Kaplan-Meier Estimates of recurrence-free survival indicate patients whose data wer...
<p>Kaplan-Meier plots depicting breast cancer related survival in response to rs12358475 genotypes i...